Exane Derivatives’s L3Harris LHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$2.66K Hold
11
﹤0.01% 421
2022
Q1
$2.73K Hold
11
﹤0.01% 733
2021
Q4
$2.35K Hold
11
﹤0.01% 655
2021
Q3
$2.42K Sell
11
-1,869
-99% -$425K ﹤0.01% 788
2021
Q2
$422K Sell
1,880
-3,604
-66% -$775K 0.1% 221
2021
Q1
$1.11M Buy
5,484
+2,678
+95% +$502K 0.32% 72
2020
Q4
$530K Buy
2,806
+20
+0.7% +$3.66K 0.16% 145
2020
Q3
$473K Buy
+2,786
New +$489K 0.14% 138
2018
Q4
Sell
-1
Closed -$169 714
2018
Q3
$169 Hold
1
﹤0.01% 599
2018
Q2
$145 Hold
1
﹤0.01% 596
2018
Q1
$160 Sell
1
-13
-93% -$1.99K ﹤0.01% 537
2017
Q4
$1.99K Sell
14
-94
-87% -$13.1K ﹤0.01% 461
2017
Q3
$14.2K Sell
108
-179
-62% -$21.5K ﹤0.01% 374
2017
Q2
$31.3K Sell
287
-55
-16% -$6.06K 0.01% 343
2017
Q1
$38K Buy
+342
New +$36.6K 0.01% 283

Other funds holding LHX

Exane Derivatives's LHX Position: Q2 2022 in Review

Exane Derivatives held its L3Harris (LHX) position steady in Q2 2022 at 11 shares worth $2.66K. The position accounts for ﹤0.01% of the portfolio, ranked #421.

Exane Derivatives first reported a position in LHX in Q1 2017 and has held it in 15 quarters since. The position peaked at $1.11M in Q1 2021. 1,203 funds tracked by Wall St. Rank hold LHX as of Q2 2022.

  • Exane Derivatives held 11 shares of L3Harris worth $2.66K as of Q2 2022.
  • Exane Derivatives left its L3Harris share count unchanged in Q2 2022.
  • L3Harris made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #421 holding.
  • Exane Derivatives first reported a position in L3Harris in Q1 2017 and has held it in 15 quarters since.
  • Exane Derivatives's L3Harris position peaked at $1.11M in Q1 2021.
  • 1,203 funds tracked by Wall St. Rank held L3Harris as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.